Trademark Overview
On Thursday, June 22, 2023, a trademark application was filed for ACEPODIA with the United States Patent and Trademark Office. The USPTO has given the ACEPODIA trademark a serial number of 98054545. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 11, 2024. This trademark is owned by Acepodia Biotechnologies Ltd.. The ACEPODIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Design and testing for new cell products namely, natural killer cell, gamma delta T cell, stem cell, and other cell products; Platform as a service (PAAS) featuring computer software platforms for developing cell products to improve ability to target tumor cells or other abnormal cells; Platform as a service (PAAS) featuring computer software platforms for use with cell therapy to manufacture tumor targeted or abnormal cell targeted cell products for use in the prevention and treatment of cancer, tumors, hematologic disease, solid cancers, hyperproliferative disease, autoimmune disease, neuronal diseases, hematopoietic cell-related diseases, metabolic syndrome, infectious diseases, immune disease or disorder, and other diseases or disorders; Providing medical and scientific research information in the field of cells and cell-derived preparations; Providing a web site featuring technology that enables users to present products in the fields of cell therapy and regenerative medicine serv...
